NewsRx

Search our medical news database

Business Update

Biotech company submits response for inclusion in Universal Protectants Proposal

Published in Bioterrorism Week, April 4th, 2005

ImmuneRegen BioSciences, a wholly owned subsidiary of IR BioSciences Holdings, Inc., (IRBO) has submitted its final response to an invitation to participate in the Canadian Defense Ministry's "Universal Protectants Proposal."

The goal of this program is to find a "universal" treatment for chemical, biological, radiological, and nuclear (CBRN) threats, such as Anthrax or dirty bombs.

The Proposal is under the auspices of the Ottawa and Suffield provencial branches of the Canadian Defense Ministry's R & D program, The CBRN Research and Technology Initiative.

"We believe Radilex to be one of the best universal protectant candidates...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Bioterrorism Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook